<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00995501</url>
  </required_header>
  <id_info>
    <org_study_id>07-010</org_study_id>
    <nct_id>NCT00995501</nct_id>
    <nct_alias>NCT00433251</nct_alias>
  </id_info>
  <brief_title>The Effects of Corticosteroids, Glucose Control, and Depth-of-Anesthesia on Perioperative Inflammation and Morbidity From Major Non-cardiac Surgery (Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT Trial))</brief_title>
  <official_title>The Effects of Corticosteroids, Glucose Control, and Depth-of-Anesthesia on Perioperative Inflammation and Morbidity From Major Non-cardiac Surgery (Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT Trial))</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>d sessler</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evidence thus suggests that steroid administration, tight glucose control, and avoidance of
      deep anesthesia may decrease perioperative morbidity by reducing the inflammatory response to
      surgery. Using a three-way factorial approach, the investigators thus propose to test the
      primary hypotheses that major perioperative morbidity is reduced by: 1) low-dose
      dexamethasone; 2) intensive perioperative glucose control; and 3) lighter anesthesia.

      Secondary hypotheses include that each intervention reduces circulating concentrations of the
      inflammatory marker CRP, and that there is a correlation between C-reactive protein (CRP) and
      post-operative complications. Anesthetic sensitivity predicts major and minor complications,
      and delirium Other secondary hypotheses are that each intervention, reduces minor surgical
      complications, reduces postoperative nausea and vomiting (PONV), reduces postoperative
      delirium, speeds hospital discharge, improves quality of life (SF-12v2 Health Survey,
      Christensen's VAS fatigue score), and reduces all-cause one-year mortality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The perioperative period is characterized by an intense inflammatory response marked by
      elevated concentrations of inflammatory markers like C-Reactive Protein (CRP). This response
      has been linked to increased perioperative morbidity and mortality. Available evidence
      suggests that blunting the inflammatory response to surgical trauma might improve
      perioperative outcomes. The putative benefits from blunting the surgical stress response are
      likely to be greatest in high-risk patients such as those having major non-cardiac surgery.
      We will study three interventions potentially modulating perioperative inflammation,
      corticosteroids, tight glucose control and light anesthesia and their effects on major
      morbidity and mortality resulting from major non-cardiac surgery.

      Steroids are the most powerful routinely available anti-inflammatory drugs. They decrease
      perioperative concentrations of inflammatory markers and improve outcomes after cardiac and
      abdominal surgery.

      Poorly controlled blood glucose worsens the inflammatory response to surgery. Hyperglycemia
      impairs wound healing, increases infection risk, increases overall hospital mortality,
      increases the risk of perioperative renal failure, and augments transfusion requirements.
      Treatment of hyperglycemia has been shown to improve outcomes and decrease mortality in
      cardiac patients. Also in critically ill patients, it decreased inflammatory markers, overall
      hospital mortality by 34%, blood stream infections by 46%, and acute renal failure by 41%.

      Cumulative deep hypnotic time is associated with increased one-year all-cause mortality,
      possibly through aggravation of the inflammatory response to surgery. In contrast, avoidance
      of deep anesthesia appears to reduce postoperative CRP levels, the risk of nausea and
      vomiting, as well as postoperative hemodynamic, respiratory and infectious complications.

      Evidence thus suggests that steroid administration, tight glucose control, and avoidance of
      deep anesthesia may decrease perioperative morbidity by reducing the inflammatory response to
      surgery. Using a three-way factorial approach, we thus propose to test the primary hypotheses
      that major perioperative morbidity is reduced by: 1) low-dose dexamethasone; 2) intensive
      perioperative glucose control; and, 3) lighter anesthesia.

      Secondary hypotheses include that each intervention reduces circulating concentrations of the
      inflammatory marker CRP, and that there is a correlation between CRP and post-operative
      complications. Anesthetic sensitivity predicts major and minor complications, and delirium
      Other secondary hypotheses are that each intervention, reduces minor surgical complications,
      reduces postoperative nausea and vomiting (PONV), reduces postoperative delirium, speeds
      hospital discharge, improves quality of life (SF-12v2 Health Survey, Christensen's VAS
      fatigue score), and reduces all-cause one-year mortality.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Per interim analysis, for futility.
  </why_stopped>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major Perioperative Morbidity</measure>
    <time_frame>30 day after surgery</time_frame>
    <description>Our primary outcome was a collapsed composite endpoint (any versus none) defined as the occurrence of at least one of sixteen major complications before hospital discharge, including sepsis, severe surgical site infection, myocardial infarction, heart failure, stroke, unstable ventricular arrhythmias, pulmonary embolism, pneumonia, respiratory failure, dialysis dependent renal failure, large pleural or peritoneal effusions, major bleeding, major wound and surgical site healing complications, vascular graft thrombosis, and 30-day mortality.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>1 Year Mortality</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>All-cause mortality</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">381</enrollment>
  <condition>Inflammation</condition>
  <condition>Perioperative Morbidity</condition>
  <arm_group>
    <arm_group_label>Intensive Glucose Control, Dexamethasone, light anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intensive Glucose Control, Dexamethasone, Deep anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intensive Glucose Control, placebo, Light anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Glucose Control, Dexamethasone, Light anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intensive Glucose Control, Placebo, Deep anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Glucose Control, Dexamethasone, Deep anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Glucose Control, Placebo, Light anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Glucose Control, Placebo, Deep anesthesia</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone Sodium Sulfate</intervention_name>
    <description>8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning</description>
    <arm_group_label>Intensive Glucose Control, Dexamethasone, light anesthesia</arm_group_label>
    <arm_group_label>Intensive Glucose Control, Dexamethasone, Deep anesthesia</arm_group_label>
    <arm_group_label>Intensive Glucose Control, placebo, Light anesthesia</arm_group_label>
    <arm_group_label>Intensive Glucose Control, Placebo, Deep anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin</intervention_name>
    <description>Insulin to maintain blood glucose 80-110 mg/dl.</description>
    <arm_group_label>Intensive Glucose Control, Dexamethasone, light anesthesia</arm_group_label>
    <arm_group_label>Intensive Glucose Control, Dexamethasone, Deep anesthesia</arm_group_label>
    <arm_group_label>Conventional Glucose Control, Dexamethasone, Light anesthesia</arm_group_label>
    <arm_group_label>Conventional Glucose Control, Dexamethasone, Deep anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>anesthesia management</intervention_name>
    <description>Light anesthesia to maintain BIS about 55</description>
    <arm_group_label>Intensive Glucose Control, Dexamethasone, light anesthesia</arm_group_label>
    <arm_group_label>Intensive Glucose Control, placebo, Light anesthesia</arm_group_label>
    <arm_group_label>Conventional Glucose Control, Dexamethasone, Light anesthesia</arm_group_label>
    <arm_group_label>Conventional Glucose Control, Placebo, Light anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dexamethasone - placebo</intervention_name>
    <description>8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning</description>
    <arm_group_label>Conventional Glucose Control, Dexamethasone, Light anesthesia</arm_group_label>
    <arm_group_label>Conventional Glucose Control, Dexamethasone, Deep anesthesia</arm_group_label>
    <arm_group_label>Conventional Glucose Control, Placebo, Light anesthesia</arm_group_label>
    <arm_group_label>Conventional Glucose Control, Placebo, Deep anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Insulin - Placebo</intervention_name>
    <description>Insulin to maintain blood glucose 180-200 mg/dl.</description>
    <arm_group_label>Intensive Glucose Control, placebo, Light anesthesia</arm_group_label>
    <arm_group_label>Intensive Glucose Control, Placebo, Deep anesthesia</arm_group_label>
    <arm_group_label>Conventional Glucose Control, Placebo, Light anesthesia</arm_group_label>
    <arm_group_label>Conventional Glucose Control, Placebo, Deep anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anesthesia management -Placebo</intervention_name>
    <description>Deep anesthesia to maintain BIS about 35</description>
    <arm_group_label>Intensive Glucose Control, Dexamethasone, Deep anesthesia</arm_group_label>
    <arm_group_label>Intensive Glucose Control, Placebo, Deep anesthesia</arm_group_label>
    <arm_group_label>Conventional Glucose Control, Dexamethasone, Deep anesthesia</arm_group_label>
    <arm_group_label>Conventional Glucose Control, Placebo, Deep anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥40 years old.

          2. Major non-cardiac surgical procedures scheduled to take ≥ two hours done under general
             anesthesia.

          3. Written informed consent

        Exclusion Criteria:

          1. Recent intravenous or oral steroid therapy (within 30 days); inhaled steroids are
             permitted

          2. Any contraindications to the proposed interventions

          3. ASA Physical Status &gt; 4

          4. Non English speaking patients

          5. Procedures done under regional anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Basem Abdelmalak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2009</study_first_submitted>
  <study_first_submitted_qc>October 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2009</study_first_posted>
  <results_first_submitted>March 15, 2017</results_first_submitted>
  <results_first_submitted_qc>March 15, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 25, 2017</results_first_posted>
  <last_update_submitted>March 15, 2017</last_update_submitted>
  <last_update_submitted_qc>March 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>d sessler</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>steroid administration</keyword>
  <keyword>tight glucose control</keyword>
  <keyword>light anesthesiReducing inflammatory response to surgical stress</keyword>
  <keyword>a</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Sodium sulfate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intensive Glucose Control, Dexamethasone, Light Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
anesthesia management: Light anesthesia to maintain BIS about 55</description>
        </group>
        <group group_id="P2">
          <title>Intensive Glucose Control, Dexamethasone, Deep Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
        <group group_id="P3">
          <title>Intensive Glucose Control, Placebo, Light Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
anesthesia management: Light anesthesia to maintain BIS about 55
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.</description>
        </group>
        <group group_id="P4">
          <title>Conventional Glucose Control, Dexamethasone, Light Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
anesthesia management: Light anesthesia to maintain BIS about 55
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning</description>
        </group>
        <group group_id="P5">
          <title>Intensive Glucose Control, Placebo, Deep Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
        <group group_id="P6">
          <title>Conventional Glucose Control, Dexamethasone, Deep Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
        <group group_id="P7">
          <title>Conventional Glucose Control, Placebo, Light Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
anesthesia management: Light anesthesia to maintain BIS about 55
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.</description>
        </group>
        <group group_id="P8">
          <title>Conventional Glucose Control, Placebo, Deep Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="51"/>
                <participants group_id="P3" count="47"/>
                <participants group_id="P4" count="46"/>
                <participants group_id="P5" count="46"/>
                <participants group_id="P6" count="44"/>
                <participants group_id="P7" count="49"/>
                <participants group_id="P8" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="51"/>
                <participants group_id="P3" count="47"/>
                <participants group_id="P4" count="46"/>
                <participants group_id="P5" count="46"/>
                <participants group_id="P6" count="44"/>
                <participants group_id="P7" count="49"/>
                <participants group_id="P8" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intensive Glucose Control, Dexamethasone, Light Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
anesthesia management: Light anesthesia to maintain BIS about 55</description>
        </group>
        <group group_id="B2">
          <title>Intensive Glucose Control, Dexamethasone, Deep Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
        <group group_id="B3">
          <title>Intensive Glucose Control, Placebo, Light Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
anesthesia management: Light anesthesia to maintain BIS about 55
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.</description>
        </group>
        <group group_id="B4">
          <title>Conventional Glucose Control, Dexamethasone, Light Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
anesthesia management: Light anesthesia to maintain BIS about 55
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning</description>
        </group>
        <group group_id="B5">
          <title>Intensive Glucose Control, Placebo, Deep Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
        <group group_id="B6">
          <title>Conventional Glucose Control, Dexamethasone, Deep Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
        <group group_id="B7">
          <title>Conventional Glucose Control, Placebo, Light Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
anesthesia management: Light anesthesia to maintain BIS about 55
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.</description>
        </group>
        <group group_id="B8">
          <title>Conventional Glucose Control, Placebo, Deep Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
        <group group_id="B9">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="52"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="47"/>
            <count group_id="B4" value="46"/>
            <count group_id="B5" value="46"/>
            <count group_id="B6" value="44"/>
            <count group_id="B7" value="49"/>
            <count group_id="B8" value="46"/>
            <count group_id="B9" value="381"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63" spread="10"/>
                    <measurement group_id="B2" value="65" spread="11"/>
                    <measurement group_id="B3" value="64" spread="11"/>
                    <measurement group_id="B4" value="64" spread="11"/>
                    <measurement group_id="B5" value="65" spread="13"/>
                    <measurement group_id="B6" value="64" spread="11"/>
                    <measurement group_id="B7" value="63" spread="12"/>
                    <measurement group_id="B8" value="65" spread="12"/>
                    <measurement group_id="B9" value="64" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="16"/>
                    <measurement group_id="B6" value="13"/>
                    <measurement group_id="B7" value="17"/>
                    <measurement group_id="B8" value="13"/>
                    <measurement group_id="B9" value="127"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="33"/>
                    <measurement group_id="B5" value="30"/>
                    <measurement group_id="B6" value="31"/>
                    <measurement group_id="B7" value="32"/>
                    <measurement group_id="B8" value="33"/>
                    <measurement group_id="B9" value="254"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="42"/>
                    <measurement group_id="B4" value="45"/>
                    <measurement group_id="B5" value="44"/>
                    <measurement group_id="B6" value="43"/>
                    <measurement group_id="B7" value="48"/>
                    <measurement group_id="B8" value="42"/>
                    <measurement group_id="B9" value="362"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="4"/>
                    <measurement group_id="B9" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28" spread="4"/>
                    <measurement group_id="B2" value="30" spread="6"/>
                    <measurement group_id="B3" value="28" spread="6"/>
                    <measurement group_id="B4" value="28" spread="8"/>
                    <measurement group_id="B5" value="28" spread="6"/>
                    <measurement group_id="B6" value="27" spread="5"/>
                    <measurement group_id="B7" value="27" spread="6"/>
                    <measurement group_id="B8" value="29" spread="6"/>
                    <measurement group_id="B9" value="28" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Major Perioperative Morbidity</title>
        <description>Our primary outcome was a collapsed composite endpoint (any versus none) defined as the occurrence of at least one of sixteen major complications before hospital discharge, including sepsis, severe surgical site infection, myocardial infarction, heart failure, stroke, unstable ventricular arrhythmias, pulmonary embolism, pneumonia, respiratory failure, dialysis dependent renal failure, large pleural or peritoneal effusions, major bleeding, major wound and surgical site healing complications, vascular graft thrombosis, and 30-day mortality.</description>
        <time_frame>30 day after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intensive Glucose Control, Dexamethasone, Light Anesthesia</title>
            <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
anesthesia management: Light anesthesia to maintain BIS about 55</description>
          </group>
          <group group_id="O2">
            <title>Intensive Glucose Control, Dexamethasone, Deep Anesthesia</title>
            <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
          </group>
          <group group_id="O3">
            <title>Intensive Glucose Control, Placebo, Light Anesthesia</title>
            <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
anesthesia management: Light anesthesia to maintain BIS about 55
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.</description>
          </group>
          <group group_id="O4">
            <title>Conventional Glucose Control, Dexamethasone, Light Anesthesia</title>
            <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
anesthesia management: Light anesthesia to maintain BIS about 55
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning</description>
          </group>
          <group group_id="O5">
            <title>Intensive Glucose Control, Placebo, Deep Anesthesia</title>
            <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
          </group>
          <group group_id="O6">
            <title>Conventional Glucose Control, Dexamethasone, Deep Anesthesia</title>
            <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
          </group>
          <group group_id="O7">
            <title>Conventional Glucose Control, Placebo, Light Anesthesia</title>
            <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
anesthesia management: Light anesthesia to maintain BIS about 55
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.</description>
          </group>
          <group group_id="O8">
            <title>Conventional Glucose Control, Placebo, Deep Anesthesia</title>
            <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
          </group>
        </group_list>
        <measure>
          <title>Major Perioperative Morbidity</title>
          <description>Our primary outcome was a collapsed composite endpoint (any versus none) defined as the occurrence of at least one of sixteen major complications before hospital discharge, including sepsis, severe surgical site infection, myocardial infarction, heart failure, stroke, unstable ventricular arrhythmias, pulmonary embolism, pneumonia, respiratory failure, dialysis dependent renal failure, large pleural or peritoneal effusions, major bleeding, major wound and surgical site healing complications, vascular graft thrombosis, and 30-day mortality.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="51"/>
                <count group_id="O3" value="47"/>
                <count group_id="O4" value="46"/>
                <count group_id="O5" value="46"/>
                <count group_id="O6" value="44"/>
                <count group_id="O7" value="49"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="11"/>
                    <measurement group_id="O8" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Compare 4 arms with intensive glucose control vs. 4 arms with conventional glucose control</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.86</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.96</param_value>
            <ci_percent>99.6</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.45</ci_lower_limit>
            <ci_upper_limit>2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Compare 4 arms with Dexamethasone vs. 4 arms with Placebo</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.87</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.96</param_value>
            <ci_percent>99.6</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.45</ci_lower_limit>
            <ci_upper_limit>2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Compare 4 arms with light anesthesia vs. 4 arms with deep anesthesia</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.90</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1</param_value>
            <ci_percent>99.6</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.49</ci_lower_limit>
            <ci_upper_limit>2.2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>1 Year Mortality</title>
        <description>All-cause mortality</description>
        <time_frame>1 year after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intensive Glucose Control, Dexamethasone, Light Anesthesia</title>
            <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
anesthesia management: Light anesthesia to maintain BIS about 55</description>
          </group>
          <group group_id="O2">
            <title>Intensive Glucose Control, Dexamethasone, Deep Anesthesia</title>
            <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
          </group>
          <group group_id="O3">
            <title>Intensive Glucose Control, Placebo, Light Anesthesia</title>
            <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
anesthesia management: Light anesthesia to maintain BIS about 55
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.</description>
          </group>
          <group group_id="O4">
            <title>Conventional Glucose Control, Dexamethasone, Light Anesthesia</title>
            <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
anesthesia management: Light anesthesia to maintain BIS about 55
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning</description>
          </group>
          <group group_id="O5">
            <title>Intensive Glucose Control, Placebo, Deep Anesthesia</title>
            <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
          </group>
          <group group_id="O6">
            <title>Conventional Glucose Control, Dexamethasone, Deep Anesthesia</title>
            <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
          </group>
          <group group_id="O7">
            <title>Conventional Glucose Control, Placebo, Light Anesthesia</title>
            <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
anesthesia management: Light anesthesia to maintain BIS about 55
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.</description>
          </group>
          <group group_id="O8">
            <title>Conventional Glucose Control, Placebo, Deep Anesthesia</title>
            <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
          </group>
        </group_list>
        <measure>
          <title>1 Year Mortality</title>
          <description>All-cause mortality</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="51"/>
                <count group_id="O3" value="47"/>
                <count group_id="O4" value="46"/>
                <count group_id="O5" value="46"/>
                <count group_id="O6" value="44"/>
                <count group_id="O7" value="49"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="7"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Compare 4 arms with intensive glucose control vs. 4 arms with conventional glucose control</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.92</param_value>
            <ci_percent>99.6</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.37</ci_lower_limit>
            <ci_upper_limit>2.3</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Compare 4 arms with Dexamethasone vs. 4 arms with Placebo</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.84</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.1</param_value>
            <ci_percent>99.6</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.43</ci_lower_limit>
            <ci_upper_limit>2.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
              <group_id>O5</group_id>
              <group_id>O6</group_id>
              <group_id>O7</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.87</p_value>
            <method>Regression, Logistic</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.1</param_value>
            <ci_percent>99.6</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.42</ci_lower_limit>
            <ci_upper_limit>2.7</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year for all-cause mortality 30-day for major complications</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Intensive Glucose Control, Dexamethasone, Light Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
anesthesia management: Light anesthesia to maintain BIS about 55</description>
        </group>
        <group group_id="E2">
          <title>Intensive Glucose Control, Dexamethasone, Deep Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
        <group group_id="E3">
          <title>Intensive Glucose Control, Placebo, Light Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
anesthesia management: Light anesthesia to maintain BIS about 55
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.</description>
        </group>
        <group group_id="E4">
          <title>Conventional Glucose Control, Dexamethasone, Light Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
anesthesia management: Light anesthesia to maintain BIS about 55
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning</description>
        </group>
        <group group_id="E5">
          <title>Intensive Glucose Control, Placebo, Deep Anesthesia</title>
          <description>Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone Sodium Sulfate: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
        <group group_id="E6">
          <title>Conventional Glucose Control, Dexamethasone, Deep Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Insulin: Insulin to maintain blood glucose 80-110 mg/dl.
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
        <group group_id="E7">
          <title>Conventional Glucose Control, Placebo, Light Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Light anesthesia target BIS of 55
anesthesia management: Light anesthesia to maintain BIS about 55
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.</description>
        </group>
        <group group_id="E8">
          <title>Conventional Glucose Control, Placebo, Deep Anesthesia</title>
          <description>Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl
Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.
Deep anesthesia target BIS of 35
Dexamethasone - placebo: 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning
Insulin - Placebo: Insulin to maintain blood glucose 180-200 mg/dl.
Anesthesia management -Placebo: Deep anesthesia to maintain BIS about 35</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="44"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="46"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="44"/>
                <counts group_id="E7" subjects_affected="11" subjects_at_risk="49"/>
                <counts group_id="E8" subjects_affected="9" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>30-day major surgical complications</sub_title>
                <description>sepsis, surgical site infection, MI, heart failure, stroke, unstable ventricular arrhythmias,PE, pneumonia, respiratory failure, renal failure, large pleural/peritoneal effusions, bleeding, healing complications, vascular graft thrombosis, mortality</description>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="52"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="51"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="47"/>
                <counts group_id="E4" events="9" subjects_affected="9" subjects_at_risk="46"/>
                <counts group_id="E5" events="10" subjects_affected="10" subjects_at_risk="46"/>
                <counts group_id="E6" events="8" subjects_affected="8" subjects_at_risk="44"/>
                <counts group_id="E7" events="11" subjects_affected="11" subjects_at_risk="49"/>
                <counts group_id="E8" events="9" subjects_affected="9" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="17" subjects_at_risk="46"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="46"/>
                <counts group_id="E6" subjects_affected="21" subjects_at_risk="44"/>
                <counts group_id="E7" subjects_affected="20" subjects_at_risk="49"/>
                <counts group_id="E8" subjects_affected="24" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>30-day minor surgical complications</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="52"/>
                <counts group_id="E2" events="25" subjects_affected="25" subjects_at_risk="51"/>
                <counts group_id="E3" events="20" subjects_affected="20" subjects_at_risk="47"/>
                <counts group_id="E4" events="17" subjects_affected="17" subjects_at_risk="46"/>
                <counts group_id="E5" events="22" subjects_affected="22" subjects_at_risk="46"/>
                <counts group_id="E6" events="21" subjects_affected="21" subjects_at_risk="44"/>
                <counts group_id="E7" events="20" subjects_affected="20" subjects_at_risk="49"/>
                <counts group_id="E8" events="24" subjects_affected="24" subjects_at_risk="46"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Daniel Sessler, MD</name_or_title>
      <organization>Cleveland clinic</organization>
      <phone>216-445-4900</phone>
      <email>sesseld@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

